首页 > 最新文献

Obesity research & clinical practice最新文献

英文 中文
The impact of internalised weight stigma and engagement with weight-inclusive approaches to health on experienced weight stigma and psychosocial health: A cross-sectional analysis of Australian community adults. 内化体重耻辱感和参与体重包容性健康方法对体重耻辱感和心理社会健康的影响:对澳大利亚社区成年人的横断面分析。
IF 2.5 4区 医学 Q3 ENDOCRINOLOGY & METABOLISM Pub Date : 2025-12-18 DOI: 10.1016/j.orcp.2025.12.006
Hugh Bidstrup, Leah Brennan, Leah Kaufmann, Alexandra Phillips, Xochitl de la Piedad Garcia

Objective: To explore the relationship between weight stigma and psychosocial health, and to characterise the extent to which individuals are engaged with weight inclusive (i.e., weight neutral, "non-diet") approaches to health. First, we aimed to (1) estimate whether internalised weight stigma mediated the relationship between experienced weight stigma and psychosocial health and (2) understand the role that awareness, engagement, and endorsement (AEE) of non-diet approaches to health might have in affecting this mediation. All methods were pre-registered (see osf.io/uwf7n).

Methods: Participants (n = 418; MAge = 36.8, SD = 12.5; MBMI = 29.5, SD = 6.8) completed an online survey on measures including non-diet AEE, weight stigma, and psychosocial health.

Results: Consistent with hypotheses, weight stigma was positively correlated with adverse psychosocial health. Internalised weight stigma mediated the relationship between experienced weight stigma and all 16 psychosocial health correlates measured, including psychological distress, disordered eating, and intuitive eating (controlling for BMI). AEE of non-diet approaches was associated with external forms of weight stigma, but not internal, self-directed weight stigma (partially supporting hypothesis). Contrary to hypotheses, there were few consistent relationships between non-diet AEE and psychosocial health correlates, and AEE of non-diet approaches to health did not moderate the hypothesised mediation effect.

Conclusion: We found that internalised weight stigma mediated experienced weight stigmas' effects, and that weight stigma was consistently related to adverse psychosocial health. However, the results were mixed for non-diet AEE. At the bivariate level, there was some indication of non-diet AEE's importance, but not at the level of our hypothesised moderating effect.

目的:探讨体重耻辱感与心理社会健康之间的关系,并描述个体采用体重包容性(即体重中性,“非饮食”)健康方法的程度。首先,我们的目的是(1)估计内在化的体重耻辱感是否介导了体重耻辱感与心理社会健康之间的关系;(2)了解非饮食健康途径的意识、参与和认可(AEE)在影响这种中介中的作用。所有方法都进行了预注册(见osf.io/uwf7n)。方法:参与者(n = 418;MAge = 36.8, SD = 12.5; MBMI = 29.5, SD = 6.8)完成了一项包括非饮食性AEE、体重耻辱感和心理健康在内的在线调查。结果:与假设一致,体重耻辱感与不良心理健康呈正相关。内化的体重耻辱感介导了体重耻辱感与所有16种心理健康相关指标之间的关系,包括心理困扰、饮食失调和直觉性饮食(控制BMI)。非饮食方法的AEE与外部形式的体重耻辱感有关,但与内部的、自我导向的体重耻辱感无关(部分支持假设)。与假设相反,非饮食性心理表达与心理健康相关因素之间几乎没有一致的关系,非饮食性心理表达对健康的影响并没有调节假设的中介效应。结论:我们发现内在化的体重耻辱感介导了经验体重耻辱感的影响,并且体重耻辱感始终与不良的心理社会健康相关。然而,非饮食AEE的结果则喜忧参半。在双变量水平上,有一些迹象表明非饮食的AEE的重要性,但不是在我们假设的调节效应的水平上。
{"title":"The impact of internalised weight stigma and engagement with weight-inclusive approaches to health on experienced weight stigma and psychosocial health: A cross-sectional analysis of Australian community adults.","authors":"Hugh Bidstrup, Leah Brennan, Leah Kaufmann, Alexandra Phillips, Xochitl de la Piedad Garcia","doi":"10.1016/j.orcp.2025.12.006","DOIUrl":"https://doi.org/10.1016/j.orcp.2025.12.006","url":null,"abstract":"<p><strong>Objective: </strong>To explore the relationship between weight stigma and psychosocial health, and to characterise the extent to which individuals are engaged with weight inclusive (i.e., weight neutral, \"non-diet\") approaches to health. First, we aimed to (1) estimate whether internalised weight stigma mediated the relationship between experienced weight stigma and psychosocial health and (2) understand the role that awareness, engagement, and endorsement (AEE) of non-diet approaches to health might have in affecting this mediation. All methods were pre-registered (see osf.io/uwf7n).</p><p><strong>Methods: </strong>Participants (n = 418; M<sub>Age</sub> = 36.8, SD = 12.5; M<sub>BMI</sub> = 29.5, SD = 6.8) completed an online survey on measures including non-diet AEE, weight stigma, and psychosocial health.</p><p><strong>Results: </strong>Consistent with hypotheses, weight stigma was positively correlated with adverse psychosocial health. Internalised weight stigma mediated the relationship between experienced weight stigma and all 16 psychosocial health correlates measured, including psychological distress, disordered eating, and intuitive eating (controlling for BMI). AEE of non-diet approaches was associated with external forms of weight stigma, but not internal, self-directed weight stigma (partially supporting hypothesis). Contrary to hypotheses, there were few consistent relationships between non-diet AEE and psychosocial health correlates, and AEE of non-diet approaches to health did not moderate the hypothesised mediation effect.</p><p><strong>Conclusion: </strong>We found that internalised weight stigma mediated experienced weight stigmas' effects, and that weight stigma was consistently related to adverse psychosocial health. However, the results were mixed for non-diet AEE. At the bivariate level, there was some indication of non-diet AEE's importance, but not at the level of our hypothesised moderating effect.</p>","PeriodicalId":19408,"journal":{"name":"Obesity research & clinical practice","volume":" ","pages":""},"PeriodicalIF":2.5,"publicationDate":"2025-12-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145794121","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Corrigendum to "Development and early evaluation of OPTIMAP: A digitally enabled nurse-led multidisciplinary pathway for care of people with severe obesity in a Public Australian Health Network" [Obesity Research & Clinical Practice, 19(6), 2025, 544-548]. “OPTIMAP的开发和早期评估:在澳大利亚公共健康网络中护理严重肥胖患者的数字化护士主导的多学科途径”的更正[肥胖研究与临床实践,19(6),2025,544-548]。
IF 2.5 4区 医学 Q3 ENDOCRINOLOGY & METABOLISM Pub Date : 2025-12-17 DOI: 10.1016/j.orcp.2025.12.007
Matthew Y Lim, Katie Belobrajdic, Melani Mallee, Marni A Nenke, Melissa Carapetis, David Jesudason, Shalvin Prasad, Adam J Nelson, Leonie Heilbronn, Elena Dicus, Gary Wittert, Emily J Meyer
{"title":"Corrigendum to \"Development and early evaluation of OPTIMAP: A digitally enabled nurse-led multidisciplinary pathway for care of people with severe obesity in a Public Australian Health Network\" [Obesity Research & Clinical Practice, 19(6), 2025, 544-548].","authors":"Matthew Y Lim, Katie Belobrajdic, Melani Mallee, Marni A Nenke, Melissa Carapetis, David Jesudason, Shalvin Prasad, Adam J Nelson, Leonie Heilbronn, Elena Dicus, Gary Wittert, Emily J Meyer","doi":"10.1016/j.orcp.2025.12.007","DOIUrl":"https://doi.org/10.1016/j.orcp.2025.12.007","url":null,"abstract":"","PeriodicalId":19408,"journal":{"name":"Obesity research & clinical practice","volume":" ","pages":""},"PeriodicalIF":2.5,"publicationDate":"2025-12-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145775275","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Vitamin D, adiposity, and cardiometabolic risk: Insights from a multivariable cross-sectional study. 维生素D、肥胖和心脏代谢风险:来自多变量横断面研究的见解。
IF 2.5 4区 医学 Q3 ENDOCRINOLOGY & METABOLISM Pub Date : 2025-12-10 DOI: 10.1016/j.orcp.2025.12.005
Carla Colombo, Valentina Fabiano, Lucia Labati, Martina Loiodice, Daniele Ceruti, Irene Campi, Valentina Cuneo, Gianvincenzo Zuccotti, Valeria Calcaterra

Introduction: Vitamin D deficiency has been implicated in various metabolic disorders, but its relationship with adiposity and atherogenic risk remains not fully elucidated. We assessed associations between serum vitamin D levels and a wide range of metabolic, atherogenic, and adiposity-related markers in adults stratified by weight status.

Methods: A cross-sectional analysis was conducted on 130 adults categorized according to their body weight status into: normal weight, overweight, and obesity. Additionally, participants were grouped based on serum vitamin D levels (threshold 20 ng/mL) Clinical, metabolic, and anthropometric variables were compared across groups. A principal component analysis (PCA) was applied to explore underlying patterns of association.

Results: As expected, significant differences in cardiometabolic parameters emerged across weight categories (p < 0.05). However, vitamin D levels showed no significant correlation with most metabolic variables in either univariate or multivariate analysis. PCA revealed that vitamin D and body mass index (BMI) were consistently represented as opposing vectors, suggesting distinct but potentially interacting influences on metabolic risk. While BMI was associated with indices such as TG/HDL, atherogenic index of plasma, and cardiometabolic risk index, vitamin D correlated more closely with HDL, total cholesterol, and Triglyceride-Cholesterol Body Index.

Conclusions: Findings indicate that vitamin D may influence cardiometabolic profiles through mechanisms that are at least partially independent of adiposity. Despite the lack of direct correlations, the divergent associations observed in PCA suggest possible interaction effects between BMI and vitamin D. Further longitudinal studies are needed to evaluate vitamin D's role as a context-dependent modulator of metabolic risk.

维生素D缺乏与多种代谢紊乱有关,但其与肥胖和动脉粥样硬化风险的关系仍未完全阐明。我们评估了血清维生素D水平与成人按体重分层的代谢、动脉粥样硬化和肥胖相关标志物之间的关系。方法:对130名成人进行横断面分析,按体重状况分为正常体重、超重和肥胖。此外,根据血清维生素D水平(阈值20 ng/mL)对参与者进行分组,比较各组的临床、代谢和人体测量变量。应用主成分分析(PCA)来探索关联的潜在模式。结果:正如预期的那样,不同体重类别的心脏代谢参数出现了显著差异(p )。结论:研究结果表明,维生素D可能通过至少部分独立于肥胖的机制影响心脏代谢谱。尽管缺乏直接相关性,但PCA中观察到的不同关联表明BMI和维生素D之间可能存在相互作用。需要进一步的纵向研究来评估维生素D作为代谢风险的上下文依赖调节剂的作用。
{"title":"Vitamin D, adiposity, and cardiometabolic risk: Insights from a multivariable cross-sectional study.","authors":"Carla Colombo, Valentina Fabiano, Lucia Labati, Martina Loiodice, Daniele Ceruti, Irene Campi, Valentina Cuneo, Gianvincenzo Zuccotti, Valeria Calcaterra","doi":"10.1016/j.orcp.2025.12.005","DOIUrl":"https://doi.org/10.1016/j.orcp.2025.12.005","url":null,"abstract":"<p><strong>Introduction: </strong>Vitamin D deficiency has been implicated in various metabolic disorders, but its relationship with adiposity and atherogenic risk remains not fully elucidated. We assessed associations between serum vitamin D levels and a wide range of metabolic, atherogenic, and adiposity-related markers in adults stratified by weight status.</p><p><strong>Methods: </strong>A cross-sectional analysis was conducted on 130 adults categorized according to their body weight status into: normal weight, overweight, and obesity. Additionally, participants were grouped based on serum vitamin D levels (threshold 20 ng/mL) Clinical, metabolic, and anthropometric variables were compared across groups. A principal component analysis (PCA) was applied to explore underlying patterns of association.</p><p><strong>Results: </strong>As expected, significant differences in cardiometabolic parameters emerged across weight categories (p < 0.05). However, vitamin D levels showed no significant correlation with most metabolic variables in either univariate or multivariate analysis. PCA revealed that vitamin D and body mass index (BMI) were consistently represented as opposing vectors, suggesting distinct but potentially interacting influences on metabolic risk. While BMI was associated with indices such as TG/HDL, atherogenic index of plasma, and cardiometabolic risk index, vitamin D correlated more closely with HDL, total cholesterol, and Triglyceride-Cholesterol Body Index.</p><p><strong>Conclusions: </strong>Findings indicate that vitamin D may influence cardiometabolic profiles through mechanisms that are at least partially independent of adiposity. Despite the lack of direct correlations, the divergent associations observed in PCA suggest possible interaction effects between BMI and vitamin D. Further longitudinal studies are needed to evaluate vitamin D's role as a context-dependent modulator of metabolic risk.</p>","PeriodicalId":19408,"journal":{"name":"Obesity research & clinical practice","volume":" ","pages":""},"PeriodicalIF":2.5,"publicationDate":"2025-12-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145743695","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The dalmatian hypertensive patients and arterial stiffness study (DALMA-HARES): Blood pressure control, body composition, and lifestyle adherence in a mediterranean population 达尔马提亚高血压患者和动脉硬化研究(DALMA-HARES):地中海人群的血压控制、身体组成和生活方式依从性。
IF 2.5 4区 医学 Q3 ENDOCRINOLOGY & METABOLISM Pub Date : 2025-11-01 DOI: 10.1016/j.orcp.2025.11.004
Josipa Radić , Hana Đogaš , Marijana Vučković , Andrea Gelemanović , Mislav Radić

Background

Croatia has high arterial hypertension (AH) and obesity rates, yet comprehensive data on the hypertensive Croatian population are lacking. This study investigated blood pressure control using 24-hour ambulatory blood pressure monitoring (24 h-ABPM) and overall characteristics of Dalmatian hypertensive patients.

Methods

This cross-sectional study enrolled 646 participants from an Outpatient Clinic for Arterial Hypertension who were prescribed antihypertensive medication or had confirmed AH by 24 h-ABPM. Participants completed the Morisky Medication Adherence Score and Mediterranean Diet Serving Score questionnaires, underwent body composition measurement, and 24 h-ABPM assessment. Medical records were reviewed.

Results

Participants had a median BMI of 28.6 kg/m² (IQR=6.6), with 38 % overweight and 39 % obese. Only 7 % adhered to Mediterranean diet (MeDi) recommendations and 50 % demonstrated high medication adherence. Sex-specific patterns emerged: men showed higher peripheral systolic and diastolic BP (p = 0.039, p = 0.001) and greater rates of unregulated diastolic and combined systolic-diastolic hypertension (p = 0.011), while women exhibited higher heart rate and augmentation index with more isolated systolic BP elevation (all p < 0.001 to p = 0.011).

Conclusions

The Dalmatian hypertensive population is characterized by high obesity prevalence (77 %), poor medication adherence (50 %), and low Mediterranean diet adherence (7 %). These findings suggest that integrating routine assessment of medication adherence, dietary patterns, and body composition with 24 h-ABPM may improve hypertension control and reduce cardiovascular complications in this high-risk population.
背景:克罗地亚动脉高血压(AH)和肥胖率很高,但缺乏克罗地亚高血压人口的综合数据。本研究通过24小时动态血压监测(24 h-ABPM)和达尔马提亚高血压患者的总体特征来研究血压控制。方法:这项横断面研究招募了来自动脉高血压门诊的646名参与者,他们服用了抗高血压药物或通过24 h-ABPM确诊了AH。参与者完成了Morisky药物依从性评分和地中海饮食服务评分问卷,进行了身体成分测量和24 h-ABPM评估。审查了医疗记录。结果:参与者的中位BMI为28.6 kg/m²(IQR=6.6),其中38% %超重,39% %肥胖。只有7% %的人坚持地中海饮食(MeDi)建议,50% %的人表现出高度的药物依从性。出现了性别特异性模式:男性表现出更高的外周收缩压和舒张压(p = 0.039,p = 0.001)和更高的不调节舒张压和合并收缩压-舒张压高血压率(p = 0.011),而女性表现出更高的心率和增强指数,更孤立的收缩压升高(p )。达尔马提亚高血压人群的特点是肥胖患病率高(77 %),药物依从性差(50 %),地中海饮食依从性低(7 %)。这些发现表明,将药物依从性、饮食模式和身体组成与24 h-ABPM相结合,可以改善高血压控制,减少这一高危人群的心血管并发症。
{"title":"The dalmatian hypertensive patients and arterial stiffness study (DALMA-HARES): Blood pressure control, body composition, and lifestyle adherence in a mediterranean population","authors":"Josipa Radić ,&nbsp;Hana Đogaš ,&nbsp;Marijana Vučković ,&nbsp;Andrea Gelemanović ,&nbsp;Mislav Radić","doi":"10.1016/j.orcp.2025.11.004","DOIUrl":"10.1016/j.orcp.2025.11.004","url":null,"abstract":"<div><h3>Background</h3><div>Croatia has high arterial hypertension (AH) and obesity rates, yet comprehensive data on the hypertensive Croatian population are lacking. This study investigated blood pressure control using 24-hour ambulatory blood pressure monitoring (24 h-ABPM) and overall characteristics of Dalmatian hypertensive patients.</div></div><div><h3>Methods</h3><div>This cross-sectional study enrolled 646 participants from an Outpatient Clinic for Arterial Hypertension who were prescribed antihypertensive medication or had confirmed AH by 24 h-ABPM. Participants completed the Morisky Medication Adherence Score and Mediterranean Diet Serving Score questionnaires, underwent body composition measurement, and 24 h-ABPM assessment. Medical records were reviewed.</div></div><div><h3>Results</h3><div>Participants had a median BMI of 28.6 kg/m² (IQR=6.6), with 38 % overweight and 39 % obese. Only 7 % adhered to Mediterranean diet (MeDi) recommendations and 50 % demonstrated high medication adherence. Sex-specific patterns emerged: men showed higher peripheral systolic and diastolic BP (p = 0.039, p = 0.001) and greater rates of unregulated diastolic and combined systolic-diastolic hypertension (p = 0.011), while women exhibited higher heart rate and augmentation index with more isolated systolic BP elevation (all p &lt; 0.001 to p = 0.011).</div></div><div><h3>Conclusions</h3><div>The Dalmatian hypertensive population is characterized by high obesity prevalence (77 %), poor medication adherence (50 %), and low Mediterranean diet adherence (7 %). These findings suggest that integrating routine assessment of medication adherence, dietary patterns, and body composition with 24 h-ABPM may improve hypertension control and reduce cardiovascular complications in this high-risk population.</div></div>","PeriodicalId":19408,"journal":{"name":"Obesity research & clinical practice","volume":"19 6","pages":"Pages 503-510"},"PeriodicalIF":2.5,"publicationDate":"2025-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145715205","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Long-term weight loss outcomes in older adults treated with obesity pharmacotherapy 接受肥胖药物治疗的老年人的长期减肥效果。
IF 2.5 4区 医学 Q3 ENDOCRINOLOGY & METABOLISM Pub Date : 2025-11-01 DOI: 10.1016/j.orcp.2025.11.002
Sarah Schmitz, Mohammad I. Bhatti, Tariq Chukir, Ampadi Karan, Zoe Verzani, Debra D’Angelo, Louis J. Aronne, Alpana P. Shukla

Objective

Data on long-term outcomes with obesity pharmacotherapy in older adults is limited. This study evaluates the long-term effectiveness and tolerability of combination therapy, including FDA approved and off-label obesity pharmacotherapy, over a mean follow-up duration of 4.4 years in adults 65 years or older compared to younger adults.

Methods

We conducted a retrospective cohort study of 428 adults aged 18–75 years with overweight or obesity who initiated obesity pharmacotherapy at an academic weight management center between 2014 and 2016. Of these, 75 were 65 years or older. Data were manually extracted from electronic medical records.

Results

Weight loss was similar between older and younger cohorts (-11.5 % ± 8.7 vs. −10.1 % ± 10.9, p = 0.243) at a mean follow-up of 4.4 years. A greater proportion of older adults achieved ≥ 5 % weight loss (81 % vs. 69 %, p = 0.027); rates of ≥ 10 %, ≥ 15 %, and ≥ 20 % weight loss were comparable. Obesity pharmacotherapy discontinuation rate due to side effects was similar between groups. Among individuals with prediabetes, the incidence of type 2 diabetes (T2D) progression was 10.7 % in older adults and 4.8 % in younger adults.

Conclusions

Older adults maintained clinically significant long-term weight loss with obesity pharmacotherapy, comparable to younger adults, with improvements in metabolic markers.
目的:老年人肥胖药物治疗的长期结果数据有限。本研究评估了联合治疗的长期有效性和耐受性,包括FDA批准的和标签外的肥胖药物治疗,在65岁或以上的成年人中与年轻人相比,平均随访时间为4.4年。方法:我们对2014年至2016年在学术体重管理中心接受肥胖药物治疗的428名18-75岁超重或肥胖成年人进行了回顾性队列研究。其中75人年龄在65岁以上。数据由人工从电子病历中提取。结果:在平均4.4年的随访中,老年人和年轻人的体重减轻相似(-11.5 %±8.7 vs -10.1 %±10.9,p = 0.243)。老年人体重减轻≥ 5 %的比例更高(81 % vs 69 %,p = 0.027);体重减轻率≥ 10 %、≥ 15 %和≥ 20 %具有可比性。两组间因副作用导致的肥胖药物治疗停药率相似。在糖尿病前期患者中,2型糖尿病(T2D)进展的发病率在老年人中为10.7 %,在年轻人中为4.8 %。结论:老年人通过肥胖药物治疗保持了临床显著的长期体重减轻,与年轻人相当,代谢指标有所改善。
{"title":"Long-term weight loss outcomes in older adults treated with obesity pharmacotherapy","authors":"Sarah Schmitz,&nbsp;Mohammad I. Bhatti,&nbsp;Tariq Chukir,&nbsp;Ampadi Karan,&nbsp;Zoe Verzani,&nbsp;Debra D’Angelo,&nbsp;Louis J. Aronne,&nbsp;Alpana P. Shukla","doi":"10.1016/j.orcp.2025.11.002","DOIUrl":"10.1016/j.orcp.2025.11.002","url":null,"abstract":"<div><h3>Objective</h3><div>Data on long-term outcomes with obesity pharmacotherapy in older adults is limited. This study evaluates the long-term effectiveness and tolerability of combination therapy, including FDA approved and off-label obesity pharmacotherapy, over a mean follow-up duration of 4.4 years in adults 65 years or older compared to younger adults.</div></div><div><h3>Methods</h3><div>We conducted a retrospective cohort study of 428 adults aged 18–75 years with overweight or obesity who initiated obesity pharmacotherapy at an academic weight management center between 2014 and 2016. Of these, 75 were 65 years or older. Data were manually extracted from electronic medical records.</div></div><div><h3>Results</h3><div>Weight loss was similar between older and younger cohorts (-11.5 % ± 8.7 vs. −10.1 % ± 10.9, p = 0.243) at a mean follow-up of 4.4 years. A greater proportion of older adults achieved ≥ 5 % weight loss (81 % vs. 69 %, p = 0.027); rates of ≥ 10 %, ≥ 15 %, and ≥ 20 % weight loss were comparable. Obesity pharmacotherapy discontinuation rate due to side effects was similar between groups. Among individuals with prediabetes, the incidence of type 2 diabetes (T2D) progression was 10.7 % in older adults and 4.8 % in younger adults.</div></div><div><h3>Conclusions</h3><div>Older adults maintained clinically significant long-term weight loss with obesity pharmacotherapy, comparable to younger adults, with improvements in metabolic markers.</div></div>","PeriodicalId":19408,"journal":{"name":"Obesity research & clinical practice","volume":"19 6","pages":"Pages 532-535"},"PeriodicalIF":2.5,"publicationDate":"2025-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145506061","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Ectopic fat deposition in intestinal wall caused the increase of L cell pyroptosis mainly through local hypoxia 肠壁脂肪异位沉积主要通过局部缺氧引起L细胞热亡增加。
IF 2.5 4区 医学 Q3 ENDOCRINOLOGY & METABOLISM Pub Date : 2025-11-01 DOI: 10.1016/j.orcp.2025.12.002
Yimeng Liu , Huihui Wu , Qianwen Ma , Zhijin Lu , Pu Zhao , Xiaoyu Li , Meiyan Li , Jie Wen

Purpose

L-cell dysfunction occurs in people with obesity, characterized by alterations in glucagon-like peptide-1 (GLP-1) secretion.The mechanism of L-cell dysfunction in obesity is not clear. This study was to reveal the mechanisms of GLP-1 secretion change of intestinal L cells in an obesity state.

Methods

The metabolic variables such as the body weight, fasting blood glucose, and blood lipids, GLP-1 secretion, local fat infiltration, hypoxia of the ileum in male mice fed with a high-fat diet (HFD, 60 % kcal from fat) and caloric-restriction diet (CRD, calories were 50 % of HFD group) were investigated. On this basis, intestinal L-cell line GLUTag cells were incubated in vitro under the environment of hypoxia or inflammation to investigate their function changes.

Results

The body weight, fasting blood glucose, blood lipids and pro-inffammatories levels of the HFD mice were increased after 2 weeks of feeding. At 6 weeks, the existence of local hypoxia was detected. It appeared simultaneously with the decrease of GLP-1 secretion and L-cell number in ileum.
In GLUTag cells cultured under hypoxia conditions, expressions of pyrogenic products gasdermin D and IL-18 were increased, cell proliferation activity was inhibited, the overall number was decreased.

Conclusion

Ectopic fat deposition of the intestinal wall caused by obesity mainly leads to an exacerbatiion of L cell pyroptosis through local hypoxia.
目的:l细胞功能障碍发生在肥胖人群中,其特征是胰高血糖素样肽-1 (GLP-1)分泌的改变。肥胖中l细胞功能障碍的机制尚不清楚。本研究旨在揭示肥胖状态下肠道L细胞GLP-1分泌变化的机制。方法:观察高脂饮食(HFD组,60% %热量来源于脂肪)和限热饮食(CRD组,50% %热量来源于脂肪)对雄性小鼠体重、空腹血糖、血脂、GLP-1分泌、局部脂肪浸润、回肠缺氧等代谢指标的影响。在此基础上,将肠道l细胞系GLUTag细胞在缺氧或炎症环境下体外培养,观察其功能变化。结果:饲喂2周后,HFD小鼠的体重、空腹血糖、血脂及促炎因子水平均有所升高。6周时检测局部缺氧的存在。与回肠GLP-1分泌减少、l细胞数量减少同时出现。在缺氧条件下培养的GLUTag细胞,热原产物气真皮蛋白D和IL-18的表达增加,细胞增殖活性受到抑制,细胞总数减少。结论:肥胖引起的肠壁脂肪异位沉积主要通过局部缺氧导致L细胞焦亡加重。
{"title":"Ectopic fat deposition in intestinal wall caused the increase of L cell pyroptosis mainly through local hypoxia","authors":"Yimeng Liu ,&nbsp;Huihui Wu ,&nbsp;Qianwen Ma ,&nbsp;Zhijin Lu ,&nbsp;Pu Zhao ,&nbsp;Xiaoyu Li ,&nbsp;Meiyan Li ,&nbsp;Jie Wen","doi":"10.1016/j.orcp.2025.12.002","DOIUrl":"10.1016/j.orcp.2025.12.002","url":null,"abstract":"<div><h3>Purpose</h3><div><span>L</span>-cell dysfunction occurs in people with obesity, characterized by alterations in glucagon-like peptide-1 (GLP-1) secretion.The mechanism of <span>L</span>-cell dysfunction in obesity is not clear. This study was to reveal the mechanisms of GLP-1 secretion change of intestinal L cells in an obesity state.</div></div><div><h3>Methods</h3><div>The metabolic variables such as the body weight, fasting blood glucose, and blood lipids, GLP-1 secretion, local fat infiltration, hypoxia of the ileum in male mice fed with a high-fat diet (HFD, 60 % kcal from fat) and caloric-restriction diet (CRD, calories were 50 % of HFD group) were investigated. On this basis, intestinal <span>L</span>-cell line GLUTag cells were incubated in vitro under the environment of hypoxia or inflammation to investigate their function changes.</div></div><div><h3>Results</h3><div>The body weight, fasting blood glucose, blood lipids and pro-inffammatories levels of the HFD mice were increased after 2 weeks of feeding. At 6 weeks, the existence of local hypoxia was detected. It appeared simultaneously with the decrease of GLP-1 secretion and <span>L</span>-cell number in ileum.</div><div>In GLUTag cells cultured under hypoxia conditions, expressions of pyrogenic products gasdermin D and IL-18 were increased, cell proliferation activity was inhibited, the overall number was decreased.</div></div><div><h3>Conclusion</h3><div>Ectopic fat deposition of the intestinal wall caused by obesity mainly leads to an exacerbatiion of L cell pyroptosis through local hypoxia.</div></div>","PeriodicalId":19408,"journal":{"name":"Obesity research & clinical practice","volume":"19 6","pages":"Pages 477-489"},"PeriodicalIF":2.5,"publicationDate":"2025-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145715265","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The influence of referral, initial assessment, and logistical factors on dropout at an adult weight management service: A semi structured interview study 转介、初始评估和后勤因素对成人体重管理服务中退出的影响:一项半结构化访谈研究。
IF 2.5 4区 医学 Q3 ENDOCRINOLOGY & METABOLISM Pub Date : 2025-11-01 DOI: 10.1016/j.orcp.2025.10.007
Jordan D. Everitt , Enzo M. Battista-Dowds , Daniel Heggs , Amanda LM Squire

Background

Patient retention is crucial to the effectiveness of weight management services; however, high dropout rates are a significant limitation. This study aimed to explore the influence of referral, initial assessment and logistical factors on dropout and retention within an NHS weight management service.

Methods

This qualitative study employed semi-structured interviews with 37 patients from an NHS weight management service. Interviews were conducted either face-to-face or via telephone, focusing on the impact of referral processes, initial consultations, intervention selection, and logistical factors on early-stage retention. Interviews were recorded, transcribed verbatim, and analysed thematically.

Results

Referrers to the weight management service reportedly had limited knowledge of the service and what it involved, and several participants expressed a desire for more detailed information at referral, which might better shape patient expectations and provide an opportunity for an informed and considered decision about engaging. Initial assessment was perceived as a critical opportunity to influence motivation, though experiences were mixed, and some viewed the appointment as perfunctory and system-focused, as opposed to person centred. Participants reported a desire for explorative discussions to align treatment options with individual needs and preferences. While most participants were satisfied with appointment scheduling and locations, travel-related issues and competing commitments emerged as barriers for a minority.

Conclusion

Early engagement stages, particularly referral and initial assessment, are pivotal in shaping patient expectations and a key opportunity to positively influence patient motivation. Participant feedback offers valuable insights for refining service delivery, which could improve retention outcomes in weight management services.
背景:患者保留对体重管理服务的有效性至关重要;然而,高辍学率是一个显著的限制。本研究旨在探讨转诊、初始评估和后勤因素对NHS体重管理服务中退出和保留的影响。方法:本定性研究采用半结构化访谈的37例患者从NHS体重管理服务。访谈通过面对面或电话进行,重点关注转诊流程、初步咨询、干预选择和后勤因素对早期保留的影响。采访被记录下来,逐字抄录,并按主题进行分析。结果:据报道,体重管理服务的转诊者对该服务及其涉及的内容了解有限,一些参与者表示希望在转诊时获得更详细的信息,这可能更好地塑造患者的期望,并为参与的知情和深思熟虑的决定提供机会。最初的评估被认为是影响动机的关键机会,尽管经历不一,一些人认为任命是敷衍和以系统为中心的,而不是以人为中心的。参与者表示希望进行探索性讨论,使治疗方案与个人需求和偏好保持一致。虽然大多数参与者对预约安排和地点感到满意,但与旅行相关的问题和相互竞争的承诺成为少数人的障碍。结论:早期参与阶段,特别是转诊和初步评估,是塑造患者期望的关键,也是积极影响患者动机的关键机会。参与者的反馈为改进服务提供了有价值的见解,这可以改善体重管理服务的保留结果。
{"title":"The influence of referral, initial assessment, and logistical factors on dropout at an adult weight management service: A semi structured interview study","authors":"Jordan D. Everitt ,&nbsp;Enzo M. Battista-Dowds ,&nbsp;Daniel Heggs ,&nbsp;Amanda LM Squire","doi":"10.1016/j.orcp.2025.10.007","DOIUrl":"10.1016/j.orcp.2025.10.007","url":null,"abstract":"<div><h3>Background</h3><div>Patient retention is crucial to the effectiveness of weight management services; however, high dropout rates are a significant limitation. This study aimed to explore the influence of referral, initial assessment and logistical factors on dropout and retention within an NHS weight management service.</div></div><div><h3>Methods</h3><div>This qualitative study employed semi-structured interviews with 37 patients from an NHS weight management service. Interviews were conducted either face-to-face or via telephone, focusing on the impact of referral processes, initial consultations, intervention selection, and logistical factors on early-stage retention. Interviews were recorded, transcribed verbatim, and analysed thematically.</div></div><div><h3>Results</h3><div>Referrers to the weight management service reportedly had limited knowledge of the service and what it involved, and several participants expressed a desire for more detailed information at referral, which might better shape patient expectations and provide an opportunity for an informed and considered decision about engaging. Initial assessment was perceived as a critical opportunity to influence motivation, though experiences were mixed, and some viewed the appointment as perfunctory and system-focused, as opposed to person centred. Participants reported a desire for explorative discussions to align treatment options with individual needs and preferences. While most participants were satisfied with appointment scheduling and locations, travel-related issues and competing commitments emerged as barriers for a minority.</div></div><div><h3>Conclusion</h3><div>Early engagement stages, particularly referral and initial assessment, are pivotal in shaping patient expectations and a key opportunity to positively influence patient motivation. Participant feedback offers valuable insights for refining service delivery, which could improve retention outcomes in weight management services.</div></div>","PeriodicalId":19408,"journal":{"name":"Obesity research & clinical practice","volume":"19 6","pages":"Pages 526-531"},"PeriodicalIF":2.5,"publicationDate":"2025-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145409761","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Emerging trends and hotspots of the link between gut probiotics and obesity from 2000 to 2024: A bibliometric analysis 2000 - 2024年肠道益生菌与肥胖之间联系的新趋势和热点:文献计量学分析。
IF 2.5 4区 医学 Q3 ENDOCRINOLOGY & METABOLISM Pub Date : 2025-11-01 DOI: 10.1016/j.orcp.2025.12.001
Xiwei Li , Mengping Wang , Zhen Zhang , Jingxin Zhou , Yufan Xie , Bin Luo , Xiaoping Yu , Yanfeng Zhu , Peiling Cai

Background

In recent decades, the global prevalence of obesity has surged, intricately linked to hypertension, stroke, type 2 diabetes, cardiovascular diseases, and cancer. However, there has been a lack of bibliometric analysis on the connection between gut probiotics and obesity.

Methods

Articles concerning gut probiotics and obesity from 1900 to 2024 were sourced from the Science Citation Index - Expanded of Web of Science Core Collection. Tools such as Microsoft Excel 2019, CiteSpace, VOSviewer, and R packages were employed to visualize publication trends and hotspots in this field.

Results

The bibliometric analysis showed that between 2000 and 2024, a total of 4604 research papers and reviews were published across 62 countries/regions. China and China Agricultural University ranked first in terms of total papers published in the past 25 years. Author Cani, Patrice D. had the highest number of publications and citations. The intersection of Nutrition & Dietetics, Food Science & Technology, and Microbiology formed the core knowledge network. Journals like “Nutrients,” “Food & Function,” and “Frontiers in Microbiology” were central to publications. Notably, “stress” and “protects” emerged as hot topics.

Conclusion

This study comprehensively reviews 25 - year research on obesity and gut probiotics. Probiotics are crucial for obesity prevention and treatment through multiple mechanisms. Their impacts on obesity - related diseases remain a key research area.
背景:近几十年来,全球肥胖患病率激增,与高血压、中风、2型糖尿病、心血管疾病和癌症有着复杂的联系。然而,关于肠道益生菌与肥胖之间关系的文献计量分析一直缺乏。方法:1900 - 2024年有关肠道益生菌与肥胖的文章来源于科学引文索引- Web of Science核心馆藏扩展版。使用Microsoft Excel 2019、CiteSpace、VOSviewer和R软件包等工具可视化该领域的出版趋势和热点。结果:文献计量分析显示,2000年至2024年,在62个国家/地区共发表了4604篇研究论文和综述。中国和中国农业大学在过去25年的论文发表总量中排名第一。作者Cani, Patrice D.发表的文章和被引用的次数最多。营养与营养学、食品科学与技术、微生物学交叉形成核心知识网络。《营养》、《食品与功能》和《微生物学前沿》等期刊是出版物的中心。值得注意的是,“压力”和“保护”成为热门话题。结论:本研究全面回顾了25年来肥胖与肠道益生菌的研究。益生菌通过多种机制对肥胖的预防和治疗至关重要。它们对肥胖相关疾病的影响仍然是一个重要的研究领域。
{"title":"Emerging trends and hotspots of the link between gut probiotics and obesity from 2000 to 2024: A bibliometric analysis","authors":"Xiwei Li ,&nbsp;Mengping Wang ,&nbsp;Zhen Zhang ,&nbsp;Jingxin Zhou ,&nbsp;Yufan Xie ,&nbsp;Bin Luo ,&nbsp;Xiaoping Yu ,&nbsp;Yanfeng Zhu ,&nbsp;Peiling Cai","doi":"10.1016/j.orcp.2025.12.001","DOIUrl":"10.1016/j.orcp.2025.12.001","url":null,"abstract":"<div><h3>Background</h3><div>In recent decades, the global prevalence of obesity has surged, intricately linked to hypertension, stroke, type 2 diabetes, cardiovascular diseases, and cancer. However, there has been a lack of bibliometric analysis on the connection between gut probiotics and obesity.</div></div><div><h3>Methods</h3><div>Articles concerning gut probiotics and obesity from 1900 to 2024 were sourced from the Science Citation Index - Expanded of Web of Science Core Collection. Tools such as Microsoft Excel 2019, CiteSpace, VOSviewer, and R packages were employed to visualize publication trends and hotspots in this field.</div></div><div><h3>Results</h3><div>The bibliometric analysis showed that between 2000 and 2024, a total of 4604 research papers and reviews were published across 62 countries/regions. China and China Agricultural University ranked first in terms of total papers published in the past 25 years. Author Cani, Patrice D. had the highest number of publications and citations. The intersection of Nutrition &amp; Dietetics, Food Science &amp; Technology, and Microbiology formed the core knowledge network. Journals like “Nutrients,” “Food &amp; Function,” and “Frontiers in Microbiology” were central to publications. Notably, “stress” and “protects” emerged as hot topics.</div></div><div><h3>Conclusion</h3><div>This study comprehensively reviews 25 - year research on obesity and gut probiotics. Probiotics are crucial for obesity prevention and treatment through multiple mechanisms. Their impacts on obesity - related diseases remain a key research area.</div></div>","PeriodicalId":19408,"journal":{"name":"Obesity research & clinical practice","volume":"19 6","pages":"Pages 457-476"},"PeriodicalIF":2.5,"publicationDate":"2025-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145696057","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Development and early evaluation of OPTIMAP: A digitally enabled nurse-led multidisciplinary pathway for care of people with severe obesity in a Public Australian Health Network OPTIMAP的开发和早期评估:澳大利亚公共健康网络中护理严重肥胖患者的数字化护士主导的多学科途径
IF 2.5 4区 医学 Q3 ENDOCRINOLOGY & METABOLISM Pub Date : 2025-11-01 DOI: 10.1016/j.orcp.2025.12.004
Matthew Y. Lim , Katie Belobrajdic , Melanie Mallee , Marni A. Nenke , Melissa Carapetis , David Jesudason , Shalvin Prasad , Adam J. Nelson , Leonie Heilbronn , Elena Dicus , Gary Wittert , Emily J. Meyer
Public obesity services in Australia face significant challenges including long wait times, fragmented care pathways, limited clinical capacity, and high administrative burden. To address these barriers, the Central Adelaide Local Health Network (CALHN) Metabolic and Bariatric Clinic (CMBC) team developed OPTIMAP (Online Pathway from Triage to Individualised Metabolic Action Plan), a digitally enabled, nurse-led model of care designed to streamline triage, enhance patient activation, and improve multidisciplinary coordination for patients with complex obesity. We outline the development process of OPTIMAP and report early outcomes from the restructured CALHN CMBC.
OPTIMAP was designed in partnership with clinicians, nursing leaders, CALHN Digital, Digivate Health, and the Personify Care platform. The pathway incorporates a digitally delivered active waitlist comprising comprehensive baseline assessment, modular obesity and obesity-related comorbidity education, behavioural tasks, red-flag monitoring, automated general practitioner communication, appointment reminders and confirmation tools. Clinician dashboards provide real-time visibility of patient progress, engagement, and risk indicators, enabling efficient preparation for personalised care.
During the first three months post-implementation, clinic capacity increased by 138 % from a pre-implementation mean of 78 appointments per month to 171 appointments per month. Failure-to-attend rates decreased by 31 %, and clinician administrative burden reduced substantially, with direct clinical care time increasing from 29 % to 52 %. Digital engagement was high, with 82 % of patients completing the baseline assessment and over 2800 educational activities completed. Patient and clinician feedback was overwhelmingly positive.
OPTIMAP represents a scalable method for integrating digital tools and nurse-led coordination to improve obesity-care efficiency and patient preparedness within public health systems.
澳大利亚的公共肥胖服务面临着巨大的挑战,包括漫长的等待时间、分散的护理途径、有限的临床能力和高行政负担。为了解决这些障碍,阿德莱德中央地方卫生网络(CALHN)代谢和减肥诊所(CMBC)团队开发了OPTIMAP(从分诊到个性化代谢行动计划的在线途径),这是一种数字化的、护士主导的护理模式,旨在简化分诊,增强患者的激活,并改善复杂肥胖患者的多学科协调。我们概述了OPTIMAP的开发过程,并报告了重组CALHN CMBC的早期结果。OPTIMAP是与临床医生、护理领导者、CALHN Digital、数字化健康和Personify护理平台合作设计的。该途径包含了一个数字交付的积极等待名单,包括全面的基线评估、模块化肥胖和肥胖相关的共病教育、行为任务、红旗监测、自动全科医生沟通、预约提醒和确认工具。临床医生仪表板提供患者进展、参与和风险指标的实时可见性,从而为个性化护理提供有效的准备。在实施后的头三个月,诊所容量从实施前的平均每月78次就诊增加到每月171次就诊,增加了138% %。缺勤率下降了31% %,临床医生的行政负担大大减轻,直接临床护理时间从29% %增加到52% %。数字参与度很高,82%( %)的患者完成了基线评估,完成了2800多项教育活动。患者和临床医生的反馈非常积极。OPTIMAP代表了一种可扩展的方法,用于整合数字工具和护士主导的协调,以提高公共卫生系统内的肥胖护理效率和患者准备。
{"title":"Development and early evaluation of OPTIMAP: A digitally enabled nurse-led multidisciplinary pathway for care of people with severe obesity in a Public Australian Health Network","authors":"Matthew Y. Lim ,&nbsp;Katie Belobrajdic ,&nbsp;Melanie Mallee ,&nbsp;Marni A. Nenke ,&nbsp;Melissa Carapetis ,&nbsp;David Jesudason ,&nbsp;Shalvin Prasad ,&nbsp;Adam J. Nelson ,&nbsp;Leonie Heilbronn ,&nbsp;Elena Dicus ,&nbsp;Gary Wittert ,&nbsp;Emily J. Meyer","doi":"10.1016/j.orcp.2025.12.004","DOIUrl":"10.1016/j.orcp.2025.12.004","url":null,"abstract":"<div><div>Public obesity services in Australia face significant challenges including long wait times, fragmented care pathways, limited clinical capacity, and high administrative burden. To address these barriers, the Central Adelaide Local Health Network (CALHN) Metabolic and Bariatric Clinic (CMBC) team developed OPTIMAP (Online Pathway from Triage to Individualised Metabolic Action Plan), a digitally enabled, nurse-led model of care designed to streamline triage, enhance patient activation, and improve multidisciplinary coordination for patients with complex obesity. We outline the development process of OPTIMAP and report early outcomes from the restructured CALHN CMBC.</div><div>OPTIMAP was designed in partnership with clinicians, nursing leaders, CALHN Digital, Digivate Health, and the Personify Care platform. The pathway incorporates a digitally delivered active waitlist comprising comprehensive baseline assessment, modular obesity and obesity-related comorbidity education, behavioural tasks, red-flag monitoring, automated general practitioner communication, appointment reminders and confirmation tools. Clinician dashboards provide real-time visibility of patient progress, engagement, and risk indicators, enabling efficient preparation for personalised care.</div><div>During the first three months post-implementation, clinic capacity increased by 138 % from a pre-implementation mean of 78 appointments per month to 171 appointments per month. Failure-to-attend rates decreased by 31 %, and clinician administrative burden reduced substantially, with direct clinical care time increasing from 29 % to 52 %. Digital engagement was high, with 82 % of patients completing the baseline assessment and over 2800 educational activities completed. Patient and clinician feedback was overwhelmingly positive.</div><div>OPTIMAP represents a scalable method for integrating digital tools and nurse-led coordination to improve obesity-care efficiency and patient preparedness within public health systems.</div></div>","PeriodicalId":19408,"journal":{"name":"Obesity research & clinical practice","volume":"19 6","pages":"Pages 544-548"},"PeriodicalIF":2.5,"publicationDate":"2025-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145736096","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Corrigendum to “Understanding the benefits and psychological burdens of using continuous glucose monitoring for lifestyle change: A mixed-methods cross-sectional study” [Obes Res Clin Pract 19 (5) (2025) 417–426] “了解使用连续血糖监测改变生活方式的益处和心理负担:一项混合方法的横断面研究”的更正[Obes Res临床实践19(5)(2025)417-426]。
IF 2.5 4区 医学 Q3 ENDOCRINOLOGY & METABOLISM Pub Date : 2025-11-01 DOI: 10.1016/j.orcp.2025.11.001
Kelli M. Richardson, Michelle R. Jospe, Jessie Somerville, Julia Felrice, Susan M. Schembre
{"title":"Corrigendum to “Understanding the benefits and psychological burdens of using continuous glucose monitoring for lifestyle change: A mixed-methods cross-sectional study” [Obes Res Clin Pract 19 (5) (2025) 417–426]","authors":"Kelli M. Richardson,&nbsp;Michelle R. Jospe,&nbsp;Jessie Somerville,&nbsp;Julia Felrice,&nbsp;Susan M. Schembre","doi":"10.1016/j.orcp.2025.11.001","DOIUrl":"10.1016/j.orcp.2025.11.001","url":null,"abstract":"","PeriodicalId":19408,"journal":{"name":"Obesity research & clinical practice","volume":"19 6","pages":"Page 550"},"PeriodicalIF":2.5,"publicationDate":"2025-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145477089","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Obesity research & clinical practice
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1